Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)

Osteoporosis International

Volumn 16, Issue 12, 2005, Pages 2080-2084

  Hurley, Marja ^a,b   Yao, Wei ^c   Lane, Nancy E ^d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bFGF; Osteoporosis; PTH

Indexed keywords

ALKALINE PHOSPHATASE; ESTROGEN; FIBROBLAST GROWTH FACTOR 2; GLUCOCORTICOID; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; PROGESTERONE;

ADULT; AGED; ARTICLE; BONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUCOCORTICOIDS; HIP; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PREDNISONE; PROGESTERONE; TERIPARATIDE; TREATMENT OUTCOME;

EID: 29044441653     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-1998-x     Document Type: Article

References (20)

1. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
2. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lane TL, Garnero P, Bouxsein ML, Biliezikian J, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207-1215
3. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216-1226
4. Hurley MM, Marie P, Florkiewicz R (2002) Fibroblast growth factor and fibroblast growth factor receptor families in bone. In: Bilezikian JP, Raisz LG, Rodan G (eds) Principles of bone biology. Academic, San Diego, pp 825-851
5. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Takatomi S, Mizoguchi J, Kato K (1993) In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9:73-80
6. Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG Sabbieti MG (1999) Parathyroid hormone regulates the expression of fibroblast growth factor 2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 14:776-783
7. Okada Y, Montero A, Zhang X, Sobue T, Lorenzo J, Doetschman T, Coffin JD, Hurley MM (2003) Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278:21258-21266
8. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627-1633
9. Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD (2000) Short term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 11:434-442
10. Buxton EC, Yao W, Lane NE (2004) Changes in serum receptor activator of nuclear factor-kappa B ligand, osteoprotegerin, and interleukin 6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab 89:3332-3336
11. Canalis E, Hock JM, Raisz LG (1994) Anabolic and catabolic effects of parathyroid hormone on bone and interactions with growth factors. The parathyroids, Chap 4, pp 65-82
12. Miyakoshi N, Kasukawa Y, Linkart T, Baylink DJ, Mohan S (2001) Evidence that the anabolic effect of PTH on bone require IGF 1 in growing mice. Endocrinology 142:4349-4356
13. Zhang X, Sobue T, Hurley MM (2002) FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cell cultures. Biochem Biophys Res Commun 290:526-531
14. Power RA, Iwanec UT, Wronski TJ (2002) Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 31:143-148
15. Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638
16. Shizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970
17. Stanislaus D, Yang X, Liang JD, Wolfe J, Cain RL, Onyia JE, Falla N, Marder P, Bidwell JP, Queener W, Hock JM (2000) In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1.34) fragment. Bone 27:209-218
18. Carroll LA, Hanasono MM, Mikullec AA, Kita M, Koch RJ (2002) Triamcinolone stimulates bFGF production and inhibits TGF beta 1 production by human derma fibroblast. Dermatol Surg 28:704-709
19. Ogata S, Yorioka N, Kohno N (2001) Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 12:2787-2796
20. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M, Sasano M, Yoshino S (2000) Effect of combinations of anti-rheumatic drugs on the production of vascular endothelial cell growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology 39:1255-1262